CHINA Hebei village becomes only COVID-19 high-risk area in China

CHINA

Hebei village becomes only COVID-19 high-risk area in China

Global Times

17:23, January 05, 2021

A kindergarten teacher takes temperatures of children on Monday in Shijiazhuang, North China's Hebei Province. The city entered "wartime mode" after reporting five coronavirus patients and 13 silent carriers over the weekend. (Photo: cnsphoto)

Health authorities on Tuesday raised the COVID-19 emergency level to “high risk” for a village in the Hebei Province capital of Shijiazhuang. The North China village of Xiaoguozhuang is currently the only high-risk area in China.

Xiaoguozhuang Village reported eight new locally transmitted cases on Tuesday. The first COVID-19 case found in Hebei Province on Sunday was from the village.

Hebei Province on Tuesday reported 14 new confirmed cases and 30 asymptomatic cases.

Another village in Shijiazhuang was designated a medium-risk area on Monday, where three local cases were newly reported Tuesday. Shijiazhuang entered "wartime mode" on Monday as part of efforts to prevent the spread of the disease.

City of Xingtai and a township in city of Zhangjiakou also announced on Tuesday that they were entering "wartime" status and strengthening all COVID-19 prevention and control measures for key personnel and areas.

As of Tuesday, China has one high-risk area and 48 medium-risk areas, of which 32 are located in Northeast China's Liaoning Province, seven in Beijing, six in Northeast China's Heilongjiang Province and three in Hebei.

China has not had a COVID-19 high-risk area since December 12.

The Chinese mainland reported 33 new COVID-19 cases on Tuesday, including 17 locally transmitted cases.

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue